baber/WOPTO huggingface dataset:
Patent IL-139843-A0 (IL)
Title: Topical administration of oxazolidinones for transdermal delivery
IPC: A61P17/02
Filed: 1999-05-26
Abstract: Disclosed is a method of treating a non-topical infection selected from the group consisting of ear infections, skin and soft tissue infections, acne, infected wounds, bacteremia, in a useful warm blooded mammal who is in need of such treatment which comprises topical administration of a pharmaceutical formulation containing a transdermally effective amount of an Oxazolidinone.
Patent IL-150457-A0 (IL)
Title: Polycyclic dianthraquinones as anti-cancer and anti-angiogenic agents
IPC: A61K31/235
Filed: 2001-01-31
Abstract: Hypericin, helianthrone and derivatives thereof of general formula (I)wherein the dotted line between positions 11 and 12 represent an optional C11-C12 bond; R is independently selected from the group consisting of hydroxy, C1-C10 alkoxy, NH-C1-C10 alkyl, and NH-hydroxy(C1-C10)alkyl; R' is independently selected from the group consisting of hydroxy and C1-C10 alkoxy; R'' is independently selected from the group consisting of hydrogen, hydroxy, C1-C10 alkoxy, NH-C1-C10 alkyl, and NH-hydroxy(C1-C10)alkyl; and R1, R2, R3, R4, R5 and R6 are independently selected from the group consisting of hydrogen, hydroxy, chloro, bromo, C1-C10 alkyl, C1-C10 alkoxy, and C1-C10 alkoxycarbonyl, provided that R'' is not hydrogen when there is a C11-C12 bond, are useful as inhibitors of angiogenesis and can be used to prevent formation of metastases and restenosis and for the treatment of angiogenesis-associated ophthalmologic disorders. In addition, the helianthrones of formula (I) can be used for the treatment of tumors in the absence of light irradiation. New compounds include those of formula I which are other than hypericin and known hypericin derivatives and there is either a C11-C12 bond or at least one R'' is other than hydrogen.
Patent IL-151240-A0 (IL)
Title: Polypropylene fibres
IPC: A61F13/00
Filed: 2001-02-19
Abstract: A polypropylene fibre including greater than 50% by weight of a first isotactic polypropylene produced by a metallocene catalyst, and from 5 to less than 50% by weight of a second isotactic polypropylene produced by a Ziegler-Natta catalyst.
Patent IL-153344-A0 (IL)
Title: Process for the selective deprotonation and functionalization of 3-substituted benzotrifluorides
IPC: C07C319/02
Filed: 2001-06-14
Abstract: 3-Substituted benzotrifluorides are selectively deprotonated and functionalized in the 2-position. The selectivity is achieved by equilibrating the mixture of lithiobenzotrifluorides initially formed in the presence of a primary or secondary amine catalyst.
Patent IL-155863-A0 (IL)
Title: Method of milling engine blocks
IPC: B23C3/14
Filed: 2001-11-14
Abstract: The present invention relates to a method of milling a material comprising aluminum and cast iron. By using a silicon nitride based cutting tool insert at a cutting speed of more than 1000 m/min, an unexpected increase in tool life has been obtained.
Patent IL-173186-A0 (IL)
Title: Catalyst for gas phase oxidations
IPC: B01J37/02
Filed: 2006-01-17
Abstract: A catalyst for gas-phase oxidations which comprises an inert support and a catalytically active composition comprising transition metal oxides applied thereto, or a precatalyst, is described. The (pre)catalyst is obtained by treating the inert support with an aqueous suspension or solution of the transition metal oxides or their precursor compounds, where the suspension contains a binder dispersion and the binder is a copolymer of an alpha-olefin and a vinyl-C<SUB>2</SUB>-C<SUB>4</SUB>-carboxylate whose vinyl C<SUB>2</SUB>-C<SUB>4</SUB>-carboxylate content is at least 62 mol %.
Patent IL-174661-A0 (IL)
Title: Flame retardant epoxy prepregs, laminates, and printed wiring boards of enhanced thermal stability
IPC: B32B27/04
Filed: 2006-03-30
Abstract: Boehmite (alumina monohydrate) when used with a typical epoxy resin advanced with phosphorus makes it possible to improve thermal stability and to increase the ignition time of laminates formed from prepregs made using this fortified resin. Such laminates have exceptionally high thermal stability and showed similar longer times to ignition as compared to corresponding resins in which alumina trihydrate was used.
Patent IL-180421-A0 (IL)
Title: 1,1'- diphosphinoferrocenes having 2, 2' - bound achirals or chiral radicals
IPC: C07F15/02
Filed: 2006-12-28
Abstract: Compounds of the formula (I) in the form of racemates, mixtures of diastereomers or pure diastereomers, where R<SUB>O </SUB>and R<SUB>oo </SUB>are each, independently of one another, hydrogen, C<SUB>1</SUB>-C<SUB>20</SUB>-alkyl, C<SUB>3</SUB>-C<SUB>8</SUB>-cycloalkyl, C<SUB>6</SUB>-C<SUB>14</SUB>-aryl or C<SUB>3</SUB>-C<SUB>12</SUB>-heteroaryl having heteroatoms selected from the group consisting of O, S and N, which are unsubstituted or substituted by C<SUB>1</SUB>-C<SUB>6</SUB>-alkyl, C<SUB>1</SUB>-C<SUB>6</SUB>-alkoxy, C<SUB>5</SUB>-C<SUB>8</SUB>-cycloalkyl, C<SUB>5</SUB>-C<SUB>8</SUB>-cycloalkoxy, phenyl, C<SUB>1</SUB>-C<SUB>6</SUB>-alkylphenyl, C<SUB>1</SUB>-C<SUB>6</SUB>-alkoxyphenyl, C<SUB>3</SUB>-C<SUB>8</SUB>-heteroaryl, F or trifluoromethyl; the radicals R<SUB>1 </SUB>are each, independently of one another, a hydrogen atom, a halogen atom or a substituent bound to the cyclopentadienyl rings via a C atom, S atom, Si atom, a P(O) or P(S) group; R<SUB>2 </SUB>and R<SUB>02 </SUB>are each, independently of one another, a hydrogen atom, C<SUB>1</SUB>-C<SUB>20</SUB>-alkyl, C<SUB>3</SUB>-C<SUB>8</SUB>-cycloalkyl, C<SUB>6</SUB>-C<SUB>14</SUB>-aryl or C<SUB>3</SUB>-C<SUB>12</SUB>-heteroaryl having heteroatoms selected from the group consisting of O, S and N, which are unsubstituted or substituted by C<SUB>1</SUB>-C<SUB>6</SUB>-alkyl, C<SUB>1</SUB>-C<SUB>6</SUB>-alkoxy, C<SUB>5</SUB>-C<SUB>8</SUB>-cycloalkyl, C<SUB>5</SUB>-C<SUB>8</SUB>-cycloalkoxy, phenyl, C<SUB>1</SUB>-C<SUB>6</SUB>-alkylphenyl, C<SUB>1</SUB>-C<SUB>6</SUB>-alkoxyphenyl, C<SUB>3</SUB>-C<SUB>8</SUB>-heteroaryl, F or trifluoromethyl; the two indices m are each, independently of one another, 1, 2 or 3; n is 0 or 1; X<SUB>1 </SUB>is a secondary phosphine group or a cyclic phosphonite group, and X<SUB>2 </SUB>and X<SUB>3 </SUB>are each, independently of one another, a secondary phosphine group. The compounds of the formula (I) are valuable ligands for enantioselective catalysts for the hydrogenation of prochiral, unsaturated compounds.
Patent IL-182438-A0 (IL)
Title: Enhanced block acknowledgement
Filed: 2007-04-10
Abstract: Embodiments disclosed herein address the need in the art for enhanced block acknowledgement. In one embodiment, a receiver indicates a decoding delay for a maximum size aggregate frame in Block Ack negotiation, which may be used by a transmitter to determine to which Block Ack Request a Block Acknowledgement is responsive. In another embodiment, a Transmission Sequence Number (TSN) may be included in a Block Ack Request. The receiver includes the TSN in the corresponding Block Ack response. This allows the transmitter to determine which frames are 'in transit.' The TSN may be used to identify blocks. In another embodiment, a TSN may be associated with one or more transmitted frames. While, the TSN is not transmitted with the Block Ack Request, the transmitter may determine which TSN corresponds with a Block Ack response in accordance with acknowledgements contained therein. Combinations of these techniques may be deployed. Various other aspects are also presented.
Patent IL-183061-A0 (IL)
Title: Aryloxyethylamine derivatives with a combination of partial dopamine d2 receptor agonism and serotonin reuptake inhibition
Filed: 2007-05-08
Abstract: The invention relates to a group of novel phenylpiperazine derivatives with a dual mode of action: serotonin reuptake inhibition and partial agonism on dopamine -D2 receptors. The invention also relates to the use of a compound disclosed herein for the manufacture of a medicament giving a beneficial effect. The compounds have the general formula (1) wherein the symbols have the meanings given in the specification.
Patent IL-217179-A0 (IL)
Title: Self-contained drive system
Filed: 2011-12-25
Abstract: The system (1) has accumulators (3) e.g. nickel metal hydride/lithium-ion accumulators, for storing and releasing power required for self-contained operation of the system. An electric motor (4) e.g. permanent magnet brushless direct current electric motor, generates a rotational movement transmitted by a mechanical transmission for the system. A controller (5) manages control of the motor and the accumulators. A casing (2) directly supports and secures the accumulators, the motor and the controller. The transmission has a plastic pinion and/or a belt that is not-reinforced by metal material.
Patent RO-126756-A0 (RO)
Title: Mechanism for kruger-flap driving
Inventor: ŢURCAN VASILE
IPC: B64C3/48
Filed: 2011-05-17
Abstract: The invention relates to a Kruger-Flap driving mechanism which determines the increase of the buoying force or protects the laminar flow on the wing rear, being used in aeronautic field for driving the hypersustentation devices and in any situation in which the rotation axis cannot be materialized. According to the invention, the mechanism consists of an electric or hydraulic actuator (5) which drives the arm (1) about an axle (9) integral with the rib (6) and drives the arm (2) by means of the axle (10) integral with the shaft, the arm (2), by means of the axle (11) drives the Kruger-Flap (3), the arm (7) which is symmetrical to the arm (1) as against the plane of rib (6), is rotated about the axle (13) and entrains the arm (8), by means of the axle (14), which, by means of the axle (12) drives the Kruger-Flap (3), the pairs of arms (1 with 7, 2 with 8) and of axles (9 with 13, 10 with 14 and 11 with 12) being symmetrical, and upon reversing the rotation direction of the actuator (5) there takes place the reverse movement of the Kruger (3).
Patent RO-130153-A0 (RO)
Title: Device for medical recovery using a 3d method for mirror-system therapy
Inventor: VER ISTVAN
IPC: G02B27/22
Filed: 2014-10-21
Abstract: The invention relates to a method and a device for mirror therapy within the kineto-therapy recovery procedures used in affections such as: cerebrovascular accident, phantom limb pain after amputation, complex regional pain syndrome following arm surgery. According to the invention, the method consists in recording the image of a patient's healthy limb, using a mirror and a video camera, and displaying this image on a monitor, so that the patient watching the monitor has the perception of the healthy limb image as the ill limb image or as the image of the amputation blunt, as the case may be. The device, as claimed by the invention, consists of a box with two compartments (A and B), where the first compartment (A) is provided with a single opening for the patient's healthy limb, inside the compartment (A) there being mounted a video camera (1) connected to a PC unit or a laptop computer (2) placed outside the box, a LED illumination source (3) and a mirror (4) which is fixed at a certain inclination, as to allow the limb to be seen, while the second compartment (B) is open on two opposite sides: one of them for the access of the therapist and the other one for the patient's affected limb or amputation blunt, at the top part a monitor (6) being mounted for allowing the patient to see, by means of 3D glasses (7), the moves of the healthy limb located in the first compartment (A) while perceiving them as the moves of the ill limb or the amputation blunt.
Patent RO-133356-A0 (RO)
Title: Device with magneto-rheologic fluid for semi-active control of hydraulic damping
Inventor: SIRETEANU TUDOR
IPC: F16F9/348
Filed: 2018-12-19
Abstract: The invention relates to a device with magneto-rheologic fluid for semi-active control of hydraulic damping, meant to be used for damping force control in a damping system with hydraulic cylinder-type actuator. According to the invention, the device comprises a body (1) having mounted therein a direction valve (SS), a control valve (SC) and an electromagnetic discharge valve (SD), the device being coupled by a connection to a chamber (C1) of a hydraulic cylinder, where a single chamber of the cylinder can be used for shock damping while, for damping oscillatory movements it uses both chambers of the hydraulic cylinder and two coupled identical devices, the direction valve (SS) having a fixed body (2) with a connection by means of which the device is coupled to the chamber of the hydraulic cylinder, the said fixed body (2) being used to block a seat (3) inside the device, by means of a nut (4), a taper closing valve (5) being able to slide inside the seat (3) and being maintained on the seat (3) by a helical spring (6), the structure of this valve (5) allowing two flowing directions: the hydraulic fluid flow from the chamber (C1) of the hydraulic cylinder, through the control valve (SC), the orifice (c12) towards the cylinder chamber (C2) and the hydraulic fluid flow from the cylinder chamber (C2) towards the chamber (C1), through the orifice (c21), opening the valve (SS), where, in case of shock damping a single flowing direction is used, from the chamber (C1) to the orifice (c12) through the valve (SC), so that the control valve ensures the variation of the flow path of the hydraulic fluid from one hydraulic cylinder chamber to another, thereby ensuring the variation of the damping force, the flow path control and the changing rate thereof being automatically achieved according to a selected control logic.
Patent MC-1750-A1 (MC)
Inventor: BEN-DOV MEIR
IPC: A61N1/36
Filed: 1984-02-08
Abstract: An external fixation device (100) in combination with an electrical stimulus generator (160) for use in the promotion of osteosynthesis in the healing of a bone fracture. Implemented as follows: using a standard external fixation device (160); fix the site of the bone fracture by inserting a first and second pair of fixation pins (112, 114, 122, 124) on each side of the fracture site; fixing at least one cathode (142) in electrical contact with the bone adjacent to the fracture site; and the cyclically applying a voltage between the fixation pins (112, 114, 122, 124) and the cathode (142). Whereby, current flows in a defined cycle from cathode (142) to one of the two pairs of fixation pins (112, 114, 122, 124), then from one pair of pins to the other, then from the cathode (142) to the other pair of electrodes.
Patent MC-1893-A1 (MC)
Inventor: BERNARD COLLIETTE
IPC: G01B3/34
Filed: 1988-02-03
Abstract: 1. Openable finger ring which can be placed on the wearing phalanx without being slipped over the articulation of the finger and which comprises an arch-shaped upper part (1) provided with an ornementation (1a) and a lower part or ring body (2), mounted for pivoting one with respect to the other by one of their ends, the other end being equipped with means for closing (4/5) and for locking (11) said parts, characterized in that the inner profile of the ring body (2) which encircles the underpart of the phalanx is polygonal and comprises two substantially parallel rectilinear lateral edges (2b/2c), extended by at least two inclined edges (2d/2e) converging toward a theoretical point situated inside the plane of symmetry of the ring, said edges (2d/2e) further comprising a stabilizing projection (2g/2h) extending through their length and designed to exert a slight pressure on the wearing phalanx in order to prevent the ring from turning over under the weight of said ornementation (1a) and thus to fix the ring in position on the finger.
Patent MC-2430-A1 (MC)
Inventor: BEAUMOND JEAN
IPC: C04B/
Filed: 1995-11-03
Abstract: Applications of various associations of bioceramic powders in their character as "biovectors" with active principles of various origins: mineral, vegetable, animal or synthetic, for the manufacture of cosmetic, pharmacological and dermatological products.
Patent IE-910180-A1 (IE)
Title: Process for the separation and concentration of gallium from¹an aqueous solution that contains gallium together with¹aluminium, zinc and/or copper
Inventor: KIRGIOS IOANNIS
IPC: C01G15/00
Filed: 1991-01-18
Abstract: Process for separating and concentrating gallium from an aqueous solution containing gallium, together with aluminium, zinc and/or copper, characterized by the following combination of features: (a) preparation of a water-in-oil emulsion consisting of a neutral or alkaline aqueous phase and an organic phase containing an oil-soluble reactant in a homogenizer in a volume ratio of aqueous phase to organic phase of 2:2 to 3:2; (b) dispersion of the water-in-oil emulsion in the aqueous solution containing gallium, which is adjusted to at least 4 mol/l of HCl, in an extractor in a volume ratio of aqueous phase to water-in-oil emulsion of 30:1 to 10:1 until droplets of the water-in-oil emulsion with a diameter less than or equal to 1 mm are obtained; (c) separation of the water-in-oil emulsion from the aqueous continuum and splitting of the emulsion in a reactor with coaxial, double-insulated electrodes in a high-voltage kV/cm and a frequency greater than 50 Hz, the unsplit portion of the water-in-oil emulsion being recycled into step (b); (d) separation of the electrocoalesced organic phase of the water-in-oil emulsion in a gravity separator and recycling of the same into step (a).
Patent IE-910438-A1 (IE)
Title: FORMATION OF HYDROXYAROMATIC KETOACETAL FROM AN¹HYDROXYAROMATIC METHYLKETONE AND PRODUCTION OF¹5-(4'-HYDROXYPHENYL) HYDANTOIN AND D-p-HYDROXYPHENYLGLYCINE¹FROM 4-HYDROXYACETOPHENONE
IPC: C07C229/36
Filed: 1991-02-11
Abstract: N-7116B The present invention provides a method for producing an hydroxyaromatic ketoacetal from an hydroxyaromatic methylketone. The invention further provides a method for producing an hydroxyaromatic ketoaldehyde from an hydroxyaromatic ketoacetal. The hydroxyaromatic ketoaldehyde can be further reacted to form a hydantoin, which hydantoin can be hydrolyzed to produce a hydroxyphenylglycine.
Patent MA-22915-A1 (MA)
Inventor: ROGELY WAITE BOYCE
IPC: A61K31/675
Filed: 1993-06-29
Abstract: A method of increasing bone mass in a human or other mammal subject afflicted with osteoporosis, comprising a thirty (30) day treatment period, comprised of a high potency phosphonate compound administration regimen wherein a) said high potency phosphonate administration regimen comprises the systemic administration to said subject of a high potency phosphonate compound at a level of from 0.00001 mgP/kg to 0.1 mgP/kg per day that said high potency phosphonate compound is administered, provided that said high potency phosphonate compound is administered at least one day of every said thirty (30) day treatment period; and wherein b) said thirty (30) day treatment period may be followed by a rest period of at least one day.
Patent MA-39002-A1 (MA)
Title: Fixation temporaire
Inventor: BIGOT FRÉDÉRIC
IPC: F16B19/10
Filed: 2014-12-15
Abstract: L'invention se rapporte à une fixation (10) pour l'assemblage temporaire d'au moins deux structures préalablement percées, du type comprenant : - un corps (11) susceptible de venir au contact d'une face des structures à assembler, - un écarteur (17) solidaire dudit corps, - deux demi-pinces élastiques (15), chaque pince étant pourvue d'un bec (16) d'accrochage; - un mécanisme déplaçable par rapport au corps, comprenant une tige (18) filetée reliée aux demi-pinces et un écrou (20) de commande monté sur ladite tige, l'écrou de commande comportant : - un taraudage (19) interne coopérant avec le filetage (25) de la tige, - un filetage (26) externe coopérant avec un taraudage (28) interne du corps, le filetage du corps et le filetage de l'écrou de commande étant de pas inversés.
Patent MA-39523-A1 (MA)
Title: Tôle d'acier laminée à chaud et procédé de fabrication associé
Inventor: PERLADE ASTRID
IPC: C22C38/14
Filed: 2015-07-10
Abstract: L'invention porte principalement sur une tôle d'acier laminée à chaud de limite d'élasticité supérieure à 680 mpa au moins en sens travers de la direction de laminage, et inférieure ou égale à 840 mpa, de résistance comprise entre 780 mpa et 950 mpa, d'allongement à rupture supérieur à 10% et de rapport d'expansion de trou (ac) supérieur ou égal à 45%, dont la composition chimique consiste, les teneurs étant exprimées en poids : 0,04% = c = 0,08% 1,2% = mn = 1,9% 0,1 % = si = 0,3% 0,07% = ti = 0,125% 0,05% = mo= 0,35% 0,15% = cr= 0,6% lorsque 0,05% = mo= 0,11%, ou 0,10% = cr= 0,6% lorsque 0,11 % = mo= 0,35% nb = 0,045% 0,005% = al = 0,1 % 0,002% = n = 0,01% s = 0,004% p=0,020% et optionnellement 0,001 % = v = 0,2% le reste étant constitué de fer et d'impuretés inévitables provenant de l'élaboration, dont la microstructure est constituée de bainite granulaire dont le pourcentage surfacique est supérieur à 70%, et de ferrite dont le pourcentage surfacique est inférieur à 20%, le complément éventuel étant constitué de bainite inférieure, de martensite et d'austénite résiduelle, la somme des teneurs en martensite et en austénite résiduelle étant inférieure à 5%. L'invention porte également sur le procédé de fabrication d'une telle tôle.
Patent MA-50738-A1 (MA)
Title: Revêtements inorganiques réactifs pour engrais agricoles
Inventor: BURNHAM JEFFREY C
IPC: C05G3/00
Filed: 2019-08-16
Abstract: L'invention concerne un engrais granulaire revêtu, les granulés étant de préférence à base de sulfate ou à base de phosphate. Lorsque les granulés sont à base de sulfate, tel que du sulfate d'ammonium, la substance de revêtement est un sel inorganique d'éléments alcalino-terreux, de préférence de calcium, de sorte que, lorsqu'elle est appliquée sur la surface d'engrais, elle forme du sulfate de calcium, de préférence un dihydrate de sulfate de calcium, en tant que revêtement protecteur.
Patent UY-25337-A1 (UY)
Title: Complejo proteico antifungico derivado de saccharomyces cerevisiae y su aplicacion
Inventor: CARRAU NELSON BRACESCO VIRGILI
IPC: A01N63/32
Filed: 1998-12-31
Abstract: PRODUCTO CONSISTENTE EN UN COMPLEJO PROTEICO DERIVADO DE UN COMPUESTO DE EXCRECIÓN DE TIPO 'KILLER',CON EL PROTEINOGRAMA DE LA FIG. 1, QUE SE OBTIENE POR INCUBACIÓN DE LEVADURAS NATIVAS SACCHAROMYCES CEREVISIAE DE TIPO 'KILLER' A 18-24sC EN UNA SUSPENSIÓN ACUOSA DE MEDIO DE CULTIVO A PH ENTRE 4 Y 5, SEGUIDA POR SEPARACIÓN DE CÉLULAS POR CENTRIFUGACIÓN, FILTRADO Y ULTRAFILTRADO DEL SOBRENADANTE,CONCENTRACIÓN ENTRE 500-800 VECES, DIÁLISIS Y SUSPENSIÓN EN SOLUCIÓN ACUOSA CONTENIENDO UN QUELANTE. EL PRODUCTO PUEDE SER USADO COMO ANTIMICÓTICO A NIVEL HUMANO.
Patent UY-26154-A1 (UY)
Title: Aril y heteroaril piridonas policíclicas sustituidas útiles para la inhibición selectiva de la cascada de coagulación
Inventor: RUEPPEL MELVIN L
IPC: C07D213/76
Filed: 2000-05-19
Abstract: La invención se refiere a compuestos de aril y heteroaril piridonas policíclicas sustituidas útiles para la inhibición de proteasas serinas de la cascada de coagulación y compuestos, composiciones y métodos para terapia anticoagulante para el tratamiento y prevención de una variedad de condiciones trombóticas inclusive enfermedades de la arteria coronaria y cerebrovasculares.
Patent UY-26479-A1 (UY)
Title: "encofrado para columnas de hormigón o mezclas aglomerantes"
Inventor: DENDI FERNANDO
Filed: 2000-12-11
Abstract: El encofrado es de forma exterior cilíndrica y permite moldear columnas de cualquier sección y forma. Su funcionamiento se basa en la igualdad de las tensiones circunferenciales de un cilindro de pared delgada, solicitado por una presión interior. El encofrado consta de dos materiales que conforman una sola pieza, un material A de aceptable comportamiento a la compresión, y un material B de buen comportamiento a la tracción. El material A es utilizado para dar forma al elemento a moldear y como relleno; el material B es la estructura resistente que contiene los esfuerzos de tracción, por sus propiedades mecánicas.